EPRX Eupraxia Pharma: Forvard narx/daromad multiplikatori

Eupraxia Pharmaceuticals (EPRX) korporativ emblemasi va logotipi

Forward P/S ko'rsatkichi Eupraxia Pharmaceuticals (EPRX) kompaniyasining bozor qiymatini namoyish etadi, bunda 0.00 qiymati ushbu ko'rsatkich darajasini ifodalaydi. Ushbu tendentsiya dori vositalarining ta'sir muddatini uzaytirish sohasidagi yetakchi olimlar jamoasi hamda mikrosfera texnologiyasi ustidan nazoratni saqlagan holda, partiyali ishlab chiqarishni tashqi zavodlarga autsorsing qilish orqali qo'llab-quvvatlanmoqda. Yuqori o'sish potentsiali R&D bosqichidan keyin patentlangan suspenziyalarning ommaviy ishlab chiqarish uchun xarajatlarning pastligi bilan ta'minlanadi.

EPRX Eupraxia Pharmaceuticals, Inc.: Kelajakdagi narxning daromadga nisbati 06.04.2024 - 06.04.2024 oraligʻida

Eupraxia Pharma (EPRX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:Eupraxia Pharmaceuticals, Inc. EPRX
Eupraxia Pharmaceuticals, Inc. tovar namunasi

Ushbu ko'rsatkich Eupraxia Pharmaceuticals (EPRX) kompaniyasining bozor qiymatini kutilayotgan yillik savdo hajmi bilan nisbatda belgilaydi, bu esa investorlarga kelajakdagi o'sish uchun qo'shimcha to'lov asosli ekanligini real vaqt rejimida baholash imkonini beradi. Joriy forward P/S darajasini tahlil qilish orqali, noyob DiffusX platformasi yuqori marja va barqaror pul oqimlari uchun asos yaratishi tasdiqlanishi mumkin, bu esa fundamental jihatdan kompaniyaning joriy bozor bahosini qo'llab-quvvatlaydi.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TBPH|AQST (Aquestive Corp) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori scPharmaceuticals Inc. (SCPH)|Forvard narx/daromad multiplikatori TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SXT Pharmaceuticals SXTC|Sotuvga nisbatan forvard narx BHST|Invizyne Technologies - Forvard P/S multiplikatori|oramed.com (ORMP) - Forvard narx/daromad multiplikatori|ENTX (enterabio.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HYFT|ABVC (ABVC BioPharma, Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori cumberlandpharma.com|Narxning prognoz qilingan daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori TELO (telomirpharma.com)|RANI - Forvard narx/daromad multiplikatori|SNYR - Narxning prognoz qilingan daromadga nisbati|rallybio.com - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP